NASDAQ : CADL

Candel Therapeutics, Inc. — Earnings Estimates

$9.56 USD

-$0.3 (-3.04%)

Volume
1.01M
Average Volume
1.94M
Market Capitalization
$700.46M
P/E Ratio
-9.72
Dividend Yield
0.00%
Price Target
$22.00
Year High
$11.36
Year Low
$4.35
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$28.05

Annual earnings financials

CADL financial data with annual/quarterly toggle

CADL GAAP EPS - Annual & Quarterly

CADL Sales Revenue - Annual & Quarterly

CADL Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

CADL Estimated and Actual Revenue by Quarter
CADL Estimated and Actual EPS by Quarter
CADL Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 1 2.98M 2.98M 2.98M 2.98M 2.98M 2.98M
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
CADL Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 1 -19.33M -19.33M -19.33M 598.57M 598.57M 598.57M
2027-09-30 0 -28.06M -28.06M -28.06M - - -
2027-06-30 0 -23.07M -23.07M -23.07M - - -
2027-03-31 0 -18.4M -18.4M -18.4M - - -
2026-12-31 0 -16.91M -16.91M -16.91M - - -
2026-09-30 0 -15.54M -14.95M -15.54M - - -
CADL Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 1 14.9M 14.9M 14.9M 1 -0.31 -0.31 -0.31
2027-09-30 0 - - - 1 -0.45 -0.45 -0.45
2027-06-30 0 - - - 1 -0.37 -0.37 -0.37
2027-03-31 0 - - - 1 -0.295 -0.295 -0.295
2026-12-31 0 - - - 1 -0.2711 -0.2711 -0.2711
2026-09-30 0 - - - 2 -0.24926 -0.23967 -0.24926